{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:51:40Z","timestamp":1792799500576,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-10658-2","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:36:12Z","timestamp":1784547372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CCR7-PERK-CREB3L1 signaling mediates tumor-associated macrophages-derived SPP1 promotion of oral squamous cell carcinoma"],"prefix":"10.1038","volume":"9","author":[{"given":"Shanfeng","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanhang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengxu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changfu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4314-6133","authenticated-orcid":false,"given":"Fayu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"10658_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007627","volume":"11","author":"Z Zhang","year":"2023","unstructured":"Zhang, Z. et al. PER2 binding to HSP90 enhances immune response against oral squamous cell carcinoma by inhibiting IKK\/NF-\u03baB pathway and PD-L1 expression. J. Immunother. Cancer 11, e007627 (2023).","journal-title":"J. Immunother. Cancer"},{"key":"10658_CR2","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2022. CA Cancer J. Clin. 72, 7\u201333 (2022).","journal-title":"CA Cancer J. Clin."},{"key":"10658_CR3","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1093\/annonc\/mdx486","volume":"28","author":"L Giraldi","year":"2017","unstructured":"Giraldi, L. et al. Alcohol and cigarette consumption predict mortality in patients with head and neck cancer: a pooled analysis within the International Head and Neck Cancer Epidemiology (INHANCE) Consortium. Ann. Oncol. 28, 2843\u20132851 (2017).","journal-title":"Ann. Oncol."},{"key":"10658_CR4","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.3390\/ijms19082413","volume":"19","author":"T Sasahira","year":"2018","unstructured":"Sasahira, T. & Kirita, T. Hallmarks of cancer-related newly prognostic factors of oral squamous cell carcinoma. Int. J. Mol. Sci. 19, 2413 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"10658_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202207017","volume":"10","author":"J Xu","year":"2023","unstructured":"Xu, J. et al. CCR7 mediated mimetic dendritic cell vaccine homing in lymph node for head and neck squamous cell carcinoma therapy. Adv. Sci. 10, e2207017 (2023).","journal-title":"Adv. Sci."},{"key":"10658_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06533-9","volume":"15","author":"J Huang","year":"2024","unstructured":"Huang, J. et al. SALL4 promotes cancer stem-like cell phenotype and radioresistance in oral squamous cell carcinomas via methyltransferase-like 3-mediated m6A modification. Cell Death Dis. 15, 139 (2024).","journal-title":"Cell Death Dis."},{"key":"10658_CR7","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1158\/2326-6066.CIR-23-0133","volume":"11","author":"YM Lee","year":"2023","unstructured":"Lee, Y. M. et al. Genomic and transcriptomic landscape of an oral squamous cell carcinoma mouse model for immunotherapy. Cancer Immunol. Res. 11, 1553\u20131567 (2023).","journal-title":"Cancer Immunol. Res."},{"key":"10658_CR8","doi-asserted-by":"publisher","first-page":"5140","DOI":"10.1158\/1078-0432.CCR-20-1695","volume":"26","author":"R Uppaluri","year":"2020","unstructured":"Uppaluri, R. et al. Neoadjuvant and adjuvant pembrolizumab in resectable locally advanced, human papillomavirus-unrelated head and neck cancer: a multicenter, phase II trial. Clin. Cancer Res. 26, 5140\u20135152 (2020).","journal-title":"Clin. Cancer Res."},{"key":"10658_CR9","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1001\/jamaoncol.2020.2955","volume":"6","author":"JD Schoenfeld","year":"2020","unstructured":"Schoenfeld, J. D. et al. Neoadjuvant nivolumab or nivolumab plus ipilimumab in untreated oral cavity squamous cell carcinoma: a phase 2 open-label randomized clinical trial. JAMA Oncol. 6, 1563\u20131570 (2020).","journal-title":"JAMA Oncol."},{"key":"10658_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13046-023-02612-5","volume":"42","author":"X Sui","year":"2023","unstructured":"Sui, X. et al. Integrative analysis of bulk and single-cell gene expression profiles to identify tumor-associated macrophage-derived CCL18 as a therapeutic target of esophageal squamous cell carcinoma. J. Exp. Clin. Cancer Res. 42, 51 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10658_CR11","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","volume":"171","author":"SV Puram","year":"2017","unstructured":"Puram, S. V. et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell 171, 1611\u20131624.e1624 (2017).","journal-title":"Cell"},{"key":"10658_CR12","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani, A., Allavena, P., Marchesi, F. & Garlanda, C. Macrophages as tools and targets in cancer therapy. Nat. Rev. Drug Discov. 21, 799\u2013820 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"10658_CR13","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/cac2.12345","volume":"42","author":"K Cheng","year":"2022","unstructured":"Cheng, K. et al. Tumor-associated macrophages in liver cancer: from mechanisms to therapy. Cancer Commun. 42, 1112\u20131140 (2022).","journal-title":"Cancer Commun."},{"key":"10658_CR14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1126\/science.ade2292","volume":"381","author":"R Bill","year":"2023","unstructured":"Bill, R. et al. CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers. Science 381, 515\u2013524 (2023).","journal-title":"Science"},{"key":"10658_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06640-7","volume":"15","author":"F Nie","year":"2024","unstructured":"Nie, F. et al. The role of CXCL2-mediated crosstalk between tumor cells and macrophages in Fusobacterium nucleatum-promoted oral squamous cell carcinoma progression. Cell Death Dis. 15, 277 (2024).","journal-title":"Cell Death Dis."},{"key":"10658_CR16","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s10238-022-00888-z","volume":"23","author":"R Qin","year":"2023","unstructured":"Qin, R. et al. Role of chemokines in the crosstalk between tumor and tumor-associated macrophages. Clin. Exp. Med. 23, 1359\u20131373 (2023).","journal-title":"Clin. Exp. Med."},{"key":"10658_CR17","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/s41418-019-0460-0","volume":"27","author":"C Liu","year":"2020","unstructured":"Liu, C. et al. Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65\/STAT3-CSN5-PD-L1 pathway. Cell Death Differ. 27, 1765\u20131781 (2020).","journal-title":"Cell Death Differ."},{"key":"10658_CR18","doi-asserted-by":"publisher","first-page":"113688","DOI":"10.1016\/j.celrep.2024.113688","volume":"43","author":"XM Li","year":"2024","unstructured":"Li, X. M. et al. Histone lactylation inhibits RAR\u03b3 expression in macrophages to promote colorectal tumorigenesis through activation of TRAF6-IL-6-STAT3 signaling. Cell Rep. 43, 113688 (2024).","journal-title":"Cell Rep."},{"key":"10658_CR19","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","volume":"181","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell 181, 442\u2013459.e429 (2020).","journal-title":"Cell"},{"key":"10658_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","volume":"15","author":"M Locati","year":"2020","unstructured":"Locati, M., Curtale, G. & Mantovani, A. Diversity, mechanisms, and significance of macrophage plasticity. Annu. Rev. Pathol. 15, 123\u2013147 (2020).","journal-title":"Annu. Rev. Pathol."},{"key":"10658_CR21","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nri2297","volume":"8","author":"R F\u00f6rster","year":"2008","unstructured":"F\u00f6rster, R., Davalos-Misslitz, A. C. & Rot, A. CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8, 362\u2013371 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"10658_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00018-023-04788-7","volume":"80","author":"LH Geraldo","year":"2023","unstructured":"Geraldo, L. H. et al. CCL21-CCR7 signaling promotes microglia\/macrophage recruitment and chemotherapy resistance in glioblastoma. Cell. Mol. Life. Sci. 80, 179 (2023).","journal-title":"Cell. Mol. Life. Sci."},{"key":"10658_CR23","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.celrep.2019.09.031","volume":"29","author":"JM Laufer","year":"2019","unstructured":"Laufer, J. M. et al. Chemokine receptor CCR7 triggers an endomembrane signaling complex for spatial Rac activation. Cell Rep. 29, 995\u20131009.e1006 (2019).","journal-title":"Cell Rep."},{"key":"10658_CR24","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.3892\/ijo.2014.2674","volume":"45","author":"FY Liu","year":"2014","unstructured":"Liu, F. Y. et al. CCR7 regulates cell migration and invasion through MAPKs in metastatic squamous cell carcinoma of head and neck. Int. J. Oncol. 45, 2502\u20132510 (2014).","journal-title":"Int. J. Oncol."},{"key":"10658_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0306-4","volume":"14","author":"E Tutunea-Fatan","year":"2015","unstructured":"Tutunea-Fatan, E., Majumder, M., Xin, X. & Lala, P. K. The role of CCL21\/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis. Mol. Cancer 14, 35 (2015).","journal-title":"Mol. Cancer"},{"key":"10658_CR26","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1002\/jcb.24629","volume":"114","author":"X Huang","year":"2013","unstructured":"Huang, X. et al. Hypoxia preconditioning of mesenchymal stromal cells enhances PC3 cell lymphatic metastasis accompanied by VEGFR-3\/CCR7 activation. J. Cell. Biochem. 114, 2834\u20132841 (2013).","journal-title":"J. Cell. Biochem."},{"key":"10658_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.dld.2010.05.013","volume":"43","author":"J Li","year":"2011","unstructured":"Li, J., Sun, R., Tao, K. & Wang, G. The CCL21\/CCR7 pathway plays a key role in human colon cancer metastasis through regulation of matrix metalloproteinase-9. Dig. Liver Dis. 43, 40\u201347 (2011).","journal-title":"Dig. Liver Dis."},{"key":"10658_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1182\/blood-2007-08-107300","volume":"111","author":"J Redondo-Mu\u00f1oz","year":"2008","unstructured":"Redondo-Mu\u00f1oz, J., Jos\u00e9 Terol, M., Garc\u00eda-Marco, J. A. & Garc\u00eda-Pardo, A. Matrix metalloproteinase-9 is up-regulated by CCL21\/CCR7 interaction via extracellular signal-regulated kinase-1\/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration. Blood 111, 383\u2013386 (2008).","journal-title":"Blood"},{"key":"10658_CR29","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ccr.2007.04.020","volume":"11","author":"JD Shields","year":"2007","unstructured":"Shields, J. D. et al. Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell 11, 526\u2013538 (2007).","journal-title":"Cancer Cell"},{"key":"10658_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12672-022-00533-x","volume":"13","author":"WH Zhou","year":"2022","unstructured":"Zhou, W. H. et al. CC chemokine receptor 7 promotes macrophage recruitment and induces M2-polarization through CC chemokine ligand 19&21 in oral squamous cell carcinoma. Discov. Oncol. 13, 67 (2022).","journal-title":"Discov. Oncol."},{"key":"10658_CR31","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13046-024-03013-y","volume":"43","author":"Z Wang","year":"2024","unstructured":"Wang, Z. et al. Analysis of the effect of CCR7 on the microenvironment of mouse oral squamous cell carcinoma by single-cell RNA sequencing technology. J. Exp. Clin. Cancer Res. 43, 94 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10658_CR32","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/s41588-022-01141-9","volume":"54","author":"D Barkley","year":"2022","unstructured":"Barkley, D. et al. Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment. Nat. Genet. 54, 1192\u20131201 (2022).","journal-title":"Nat. Genet."},{"key":"10658_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41587-019-0392-8","volume":"38","author":"R Moncada","year":"2020","unstructured":"Moncada, R. et al. Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas. Nat. Biotechnol. 38, 333\u2013342 (2020).","journal-title":"Nat. Biotechnol."},{"key":"10658_CR34","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel, A. P. et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396\u20131401 (2014).","journal-title":"Science"},{"key":"10658_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202400524","volume":"11","author":"L Dong","year":"2024","unstructured":"Dong, L. et al. SPP1(+) TAM regulates the metastatic colonization of CXCR4(+) metastasis-associated tumor cells by remodeling the lymph node microenvironment. Adv. Sci. 11, e2400524 (2024).","journal-title":"Adv. Sci."},{"key":"10658_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202410360","volume":"12","author":"B Kartal","year":"2025","unstructured":"Kartal, B. et al. Targeted SPP1 inhibition of tumor-associated myeloid cells effectively decreases tumor sizes. Adv. Sci 12, e2410360 (2025).","journal-title":"Adv. Sci"},{"key":"10658_CR37","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41590-022-01145-x","volume":"23","author":"LN Raines","year":"2022","unstructured":"Raines, L. N. et al. PERK is a critical metabolic hub for immunosuppressive function in macrophages. Nat. Immunol. 23, 431\u2013445 (2022).","journal-title":"Nat. Immunol."},{"key":"10658_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01052-y","volume":"8","author":"YX Feng","year":"2017","unstructured":"Feng, Y. X. et al. Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1. Nat. Commun. 8, 1079 (2017).","journal-title":"Nat. Commun."},{"key":"10658_CR39","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.cell.2019.07.028","volume":"178","author":"K Jaeger","year":"2019","unstructured":"Jaeger, K. et al. Structural basis for allosteric ligand recognition in the human CC chemokine receptor 7. Cell 178, 1222\u20131230.e1210 (2019).","journal-title":"Cell"},{"key":"10658_CR40","doi-asserted-by":"publisher","first-page":"102024","DOI":"10.1016\/j.xcrm.2025.102024","volume":"6","author":"YT Liu","year":"2025","unstructured":"Liu, Y. T. et al. Immune-featured stromal niches associate with response to neoadjuvant immunotherapy in oral squamous cell carcinoma. Cell Rep. Med. 6, 102024 (2025).","journal-title":"Cell Rep. Med."},{"key":"10658_CR41","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.174618","volume":"9","author":"HS Eain","year":"2024","unstructured":"Eain, H. S. et al. Double-faced CX3CL1 enhances lymphangiogenesis-dependent metastasis in an aggressive subclone of oral squamous cell carcinoma. JCI Insight 9, e174618 (2024).","journal-title":"JCI Insight"},{"key":"10658_CR42","first-page":"188499","volume":"1875","author":"A Salem","year":"2021","unstructured":"Salem, A., Alotaibi, M., Mroueh, R., Basheer, H. A. & Afarinkia, K. CCR7 as a therapeutic target in Cancer. Acta Rev. Cancer 1875, 188499 (2021).","journal-title":"Acta Rev. Cancer"},{"key":"10658_CR43","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860\u2013867 (2002).","journal-title":"Nature"},{"key":"10658_CR44","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"10658_CR45","doi-asserted-by":"publisher","first-page":"101924","DOI":"10.1016\/j.tranon.2024.101924","volume":"44","author":"C Yan","year":"2024","unstructured":"Yan, C. et al. CCR7 affects the tumor microenvironment by regulating the activation of na\u00efve CD8(+) T cells to promote the proliferation of oral squamous cell carcinoma. Transl. Oncol. 44, 101924 (2024).","journal-title":"Transl. Oncol."},{"key":"10658_CR46","doi-asserted-by":"publisher","first-page":"111305","DOI":"10.1016\/j.cellsig.2024.111305","volume":"122","author":"J Gao","year":"2024","unstructured":"Gao, J. et al. CCR7\/DUSP1 signaling Axis mediates iCAF to regulates head and neck squamous cell carcinoma growth. Cell. Signal. 122, 111305 (2024).","journal-title":"Cell. Signal."},{"key":"10658_CR47","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s43018-021-00196-7","volume":"2","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. The IRENA lncRNA converts chemotherapy-polarized tumor-suppressing macrophages to tumor-promoting phenotypes in breast cancer. Nat. Cancer 2, 457\u2013473 (2021).","journal-title":"Nat. Cancer"},{"key":"10658_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02064-1","volume":"23","author":"X Chu","year":"2024","unstructured":"Chu, X., Tian, Y. & Lv, C. Decoding the spatiotemporal heterogeneity of tumor-associated macrophages. Mol. Cancer 23, 150 (2024).","journal-title":"Mol. Cancer"},{"key":"10658_CR49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","volume":"6","author":"X Xiang","year":"2021","unstructured":"Xiang, X., Wang, J., Lu, D. & Xu, X. Targeting tumor-associated macrophages to synergize tumor immunotherapy. Signal Transduct. Target. Ther. 6, 75 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"10658_CR50","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13046-025-03303-z","volume":"44","author":"Z Pan","year":"2025","unstructured":"Pan, Z. et al. VSIG4(+) tumor-associated macrophages mediate neutrophil infiltration and impair antigen-specific immunity in aggressive cancers through epigenetic regulation of SPP1. J. Exp. Clin. Cancer Res. 44, 45 (2025).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10658_CR51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41421-023-00563-x","volume":"9","author":"H He","year":"2023","unstructured":"He, H. et al. Multi-dimensional single-cell characterization revealed suppressive immune microenvironment in AFP-positive hepatocellular carcinoma. Cell Discov. 9, 60 (2023).","journal-title":"Cell Discov."},{"key":"10658_CR52","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1136\/gutjnl-2024-333617","volume":"74","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases. Gut 74, 350\u2013363 (2025).","journal-title":"Gut"},{"key":"10658_CR53","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s13046-024-03255-w","volume":"43","author":"C Liu","year":"2024","unstructured":"Liu, C. et al. SPP1+\u2009macrophages promote head and neck squamous cell carcinoma progression by secreting TNF-\u03b1 and IL-1\u03b2. J. Exp. Clin. Cancer Res. 43, 332 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10658_CR54","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.it.2023.10.007","volume":"44","author":"I Nasir","year":"2023","unstructured":"Nasir, I. et al. Tumor macrophage functional heterogeneity can inform the development of novel cancer therapies. Trends Immunol. 44, 971\u2013985 (2023).","journal-title":"Trends Immunol."},{"key":"10658_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29366-6","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi, J. et al. Single-cell and spatial analysis reveal interaction of FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer. Nat. Commun. 13, 1742 (2022).","journal-title":"Nat. Commun."},{"key":"10658_CR56","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng, S. et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell 184, 792\u2013809.e723 (2021).","journal-title":"Cell"},{"key":"10658_CR57","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ccell.2016.08.002","volume":"30","author":"M Ahmed","year":"2016","unstructured":"Ahmed, M. et al. An osteopontin\/CD44 axis in RhoGDI2-mediated metastasis suppression. Cancer Cell 30, 432\u2013443 (2016).","journal-title":"Cancer Cell"},{"key":"10658_CR58","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13045-020-01009-7","volume":"13","author":"Y Fu","year":"2020","unstructured":"Fu, Y. et al. Abnormally activated OPN\/integrin \u03b1V\u03b23\/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer. J. Hematol. Oncol. 13, 169 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"10658_CR59","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1053\/j.gastro.2021.08.023","volume":"161","author":"P Nallasamy","year":"2021","unstructured":"Nallasamy, P. et al. Pancreatic tumor microenvironment factor promotes cancer stemness via SPP1-CD44 axis. Gastroenterology 161, 1998\u20132013.e1997 (2021).","journal-title":"Gastroenterology"},{"key":"10658_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01658-x","volume":"21","author":"Z Pan","year":"2022","unstructured":"Pan, Z. et al. CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment. Mol. Cancer 21, 190 (2022).","journal-title":"Mol. Cancer"},{"key":"10658_CR61","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41368-024-00322-y","volume":"16","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. CREB3L1 deficiency impairs odontoblastic differentiation and molar dentin deposition partially through the TMEM30B. Int. J. Oral. Sci. 16, 59 (2024).","journal-title":"Int. J. Oral. Sci."},{"key":"10658_CR62","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010029","volume":"13","author":"H Xu","year":"2025","unstructured":"Xu, H. et al. CREB3L1 facilitates pancreatic tumor progression and reprograms intratumoral tumor-associated macrophages to shape an immunotherapy-resistance microenvironment. J. Immunother. Cancer 13, e010029 (2025).","journal-title":"J. Immunother. Cancer"},{"key":"10658_CR63","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf3657","volume":"7","author":"H Luo","year":"2021","unstructured":"Luo, H. et al. Characterizing dedifferentiation of thyroid cancer by integrated analysis. Sci. Adv. 7, eabf3657 (2021).","journal-title":"Sci. Adv."},{"key":"10658_CR64","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/PAS.0000000000000158","volume":"38","author":"E Arbajian","year":"2014","unstructured":"Arbajian, E. et al. Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma. Am. J. Surg. Pathol. 38, 801\u2013808 (2014).","journal-title":"Am. J. Surg. Pathol."},{"key":"10658_CR65","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.humpath.2014.05.006","volume":"45","author":"DL Stockman","year":"2014","unstructured":"Stockman, D. L., Ali, S. M., He, J., Ross, J. S. & Meis, J. M. Sclerosing epithelioid fibrosarcoma presenting as intraabdominal sarcomatosis with a novel EWSR1-CREB3L1 gene fusion. Hum. Pathol. 45, 2173\u20132178 (2014).","journal-title":"Hum. Pathol."},{"key":"10658_CR66","doi-asserted-by":"publisher","first-page":"123","DOI":"10.7150\/ijms.90189","volume":"21","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. The regulatory network of CREB3L1 and its roles in physiological and pathological conditions. Int. J. Med. Sci. 21, 123\u2013136 (2024).","journal-title":"Int. J. Med. Sci."},{"key":"10658_CR67","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.bone.2010.10.176","volume":"48","author":"T Murakami","year":"2011","unstructured":"Murakami, T. et al. Distinct mechanisms are responsible for osteopenia and growth retardation in OASIS-deficient mice. Bone 48, 514\u2013523 (2011).","journal-title":"Bone"},{"key":"10658_CR68","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1158\/0008-5472.CAN-19-3108","volume":"80","author":"JM Harnoss","year":"2020","unstructured":"Harnoss, J. M. et al. IRE1\u03b1 disruption in triple-negative breast cancer cooperates with antiangiogenic therapy by reversing er stress adaptation and remodeling the tumor microenvironment. Cancer Res. 80, 2368\u20132379 (2020).","journal-title":"Cancer Res."},{"key":"10658_CR69","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.ccell.2022.08.016","volume":"40","author":"JK Mandula","year":"2022","unstructured":"Mandula, J. K. et al. Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responses. Cancer Cell 40, 1145\u20131160.e1149 (2022).","journal-title":"Cancer Cell"},{"key":"10658_CR70","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1158\/2159-8290.CD-13-0945","volume":"4","author":"YX Feng","year":"2014","unstructured":"Feng, Y. X. et al. Epithelial-to-mesenchymal transition activates PERK-eIF2\u03b1 and sensitizes cells to endoplasmic reticulum stress. Cancer Discov. 4, 702\u2013715 (2014).","journal-title":"Cancer Discov."},{"key":"10658_CR71","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.canlet.2021.05.021","volume":"515","author":"W Cai","year":"2021","unstructured":"Cai, W. et al. PERK-eIF2\u03b1-ERK1\/2 axis drives mesenchymal-endothelial transition of cancer-associated fibroblasts in pancreatic cancer. Cancer Lett. 515, 86\u201395 (2021).","journal-title":"Cancer Lett."},{"key":"10658_CR72","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.1002\/jcp.29525","volume":"235","author":"Y Chen","year":"2020","unstructured":"Chen, Y. et al. CCL21\/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2\/STAT3 signaling pathway. J. Cell. Physiol. 235, 5995\u20136009 (2020).","journal-title":"J. Cell. Physiol."},{"key":"10658_CR73","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s43018-023-00658-0","volume":"5","author":"L Zhao","year":"2024","unstructured":"Zhao, L. et al. Lymphatic endothelial-like cells promote glioblastoma stem cell growth through cytokine-driven cholesterol metabolism. Nat. Cancer 5, 147\u2013166 (2024).","journal-title":"Nat. Cancer"},{"key":"10658_CR74","doi-asserted-by":"publisher","first-page":"4815","DOI":"10.4049\/jimmunol.173.8.4815","volume":"173","author":"M Ato","year":"2004","unstructured":"Ato, M., Nakano, H., Kakiuchi, T. & Kaye, P. M. Localization of marginal zone macrophages is regulated by C-C chemokine ligands 21\/19. J. Immunol. 173, 4815\u20134820 (2004).","journal-title":"J. Immunol."},{"key":"10658_CR75","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04072-23","volume":"12","author":"J Samolej","year":"2024","unstructured":"Samolej, J. et al. Bisbenzimide compounds inhibit the replication of prototype and pandemic potential poxviruses. Microbiol. Spectr. 12, e0407223 (2024).","journal-title":"Microbiol. Spectr."},{"key":"10658_CR76","doi-asserted-by":"publisher","first-page":"6297","DOI":"10.1016\/j.bmcl.2012.06.102","volume":"22","author":"XJ Wang","year":"2012","unstructured":"Wang, X. J. et al. Newly synthesized bis-benzimidazole derivatives exerting anti-tumor activity through induction of apoptosis and autophagy. Bioorg. Med. Chem. Lett. 22, 6297\u20136300 (2012).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10658_CR77","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/bjc.1985.252","volume":"52","author":"PL Olive","year":"1985","unstructured":"Olive, P. L., Chaplin, D. J. & Durand, R. E. Pharmacokinetics, binding and distribution of Hoechst 33342 in spheroids and murine tumours. Br. J. Cancer 52, 739\u2013746 (1985).","journal-title":"Br. J. Cancer"},{"key":"10658_CR78","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1158\/1078-0432.CCR-06-0802","volume":"13","author":"N Crokart","year":"2007","unstructured":"Crokart, N. et al. Glucocorticoids modulate tumor radiation response through a decrease in tumor oxygen consumption. Clin. Cancer Res. 13, 630\u2013635 (2007).","journal-title":"Clin. Cancer Res."},{"key":"10658_CR79","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/oncolo\/oyae108","volume":"29","author":"ZG Xia","year":"2024","unstructured":"Xia, Z. G. et al. Phase 2 study of pegylated liposomal doxorubicin plus cyclophosphamide, vincristine\/vindesine, and prednisone in newly diagnosed PTCL: 8-year results. Oncologist 29, 819\u2013e1223 (2024).","journal-title":"Oncologist"},{"key":"10658_CR80","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1200\/JCO.21.00358","volume":"39","author":"PJ Leavey","year":"2021","unstructured":"Leavey, P. J. et al. Phase III trial adding vincristine-topotecan-cyclophosphamide to the initial treatment of patients with nonmetastatic ewing sarcoma: a children\u2019s oncology group report. J. Clin. Oncol. 39, 4029\u20134038 (2021).","journal-title":"J. Clin. Oncol."},{"key":"10658_CR81","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00280-014-2496-7","volume":"74","author":"H Ishiguro","year":"2014","unstructured":"Ishiguro, H. et al. Differential regulation of bladder cancer growth by various glucocorticoids: corticosterone and prednisone inhibit cell invasion without promoting cell proliferation or reducing cisplatin cytotoxicity. Cancer Chemother. Pharmacol. 74, 249\u2013255 (2014).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10658_CR82","doi-asserted-by":"publisher","first-page":"9038","DOI":"10.1158\/0008-5472.CAN-05-0882","volume":"65","author":"S Emanuel","year":"2005","unstructured":"Emanuel, S. et al. The in vitro and in vivo effects of JNJ-7706621: a dual inhibitor of cyclin-dependent kinases and aurora kinases. Cancer Res. 65, 9038\u20139046 (2005).","journal-title":"Cancer Res."},{"key":"10658_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10882-7","volume":"23","author":"D Xu","year":"2023","unstructured":"Xu, D. et al. CCL19\/CCR7 drives regulatory T cell migration and indicates poor prognosis in gastric cancer. BMC Cancer 23, 464 (2023).","journal-title":"BMC Cancer"},{"key":"10658_CR84","doi-asserted-by":"publisher","first-page":"9375885","DOI":"10.1155\/jimr\/9375885","volume":"2025","author":"M Zhang","year":"2025","unstructured":"Zhang, M. et al. Identification of a prognostic signature based on tumor-infiltrating B lymphocyte mRNA in head and neck squamous cell carcinoma. J. Immunol. Res. 2025, 9375885 (2025).","journal-title":"J. Immunol. Res."},{"key":"10658_CR85","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/j.ccell.2025.07.015","volume":"43","author":"JR Grandis","year":"2025","unstructured":"Grandis, J. R. et al. Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer. Cancer Cell 43, 2051\u20132068.e2059 (2025).","journal-title":"Cancer Cell"},{"key":"10658_CR86","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/hed.27722","volume":"46","author":"V Kansal","year":"2024","unstructured":"Kansal, V., Kinney, B. L. C. & Schmitt, N. C. Characterization of the tumor microenvironment in the mouse oral cancer (MOC1) model after orthotopic implantation in the buccal mucosa. Head. Neck 46, 1056\u20131062 (2024).","journal-title":"Head. Neck"},{"key":"10658_CR87","doi-asserted-by":"publisher","unstructured":"Lin, S. F. CCR7-PERK-CREB3L1 signaling mediates tumor-associated macrophages-derived SPP1 promotion of oral squamous cell carcinoma. Zenodo https:\/\/doi.org\/10.5281\/zenodo.6891716 (2026).","DOI":"10.5281\/zenodo.6891716"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10658-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10658-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10658-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:03:19Z","timestamp":1788800599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10658-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10658"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10658-2","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1176"}}